Literature DB >> 17100874

Bone marrow versus thymic pathways of natural killer cell development.

James P Di Santo1, Christian A J Vosshenrich.   

Abstract

Understanding natural killer (NK) cell developmental pathways is crucial for harnessing the potential therapeutic benefits of this specialized lymphocyte subset. The bone marrow (BM) plays a major role in NK cell development, providing the appropriate environmental cues for NK cell commitment and subsequent NK cell differentiation. Nevertheless, the molecular signals provided in this context remain enigmatic. It is widely assumed that BM seeds the periphery with NK cells. However, the precise origins of NK cells found in lymphoid organs and tissues are not defined. Recently, we found that thymic NK cells bear molecular markers and functional attributes that distinguish them from most peripheral NK cells. We find that NK cells are actively exported from the thymus to the periphery, suggesting that thymus-derived NK cells may have unique roles both intrathymically and in secondary lymphoid organs. Here we compare the properties of thymic NK cells with properties of other NK cell subsets that have been identified in the mouse. We propose that heterogeneity in NK cell function can be achieved through distinct thymic and bone marrow pathways of NK cell development.

Entities:  

Mesh:

Year:  2006        PMID: 17100874     DOI: 10.1111/j.1600-065X.2006.00461.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  37 in total

1.  Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1.

Authors:  Marine Champsaur; Joshua N Beilke; Kouetsu Ogasawara; Ulrich H Koszinowski; Stipan Jonjic; Lewis L Lanier
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Chronic alcohol consumption decreases the percentage and number of NK cells in the peripheral lymph nodes and exacerbates B16BL6 melanoma metastasis into the draining lymph nodes.

Authors:  Hui Zhang; Zhaohui Zhu; Gary G Meadows
Journal:  Cell Immunol       Date:  2010-10-25       Impact factor: 4.868

Review 3.  Extrinsic and intrinsic regulation of early natural killer cell development.

Authors:  Markus D Boos; Kevin Ramirez; Barbara L Kee
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 4.  Bone specific immunity and its impact on metastasis.

Authors:  Nikola Baschuk; Jay Rautela; Belinda S Parker
Journal:  Bonekey Rep       Date:  2015-04-15

Review 5.  Innate lymphoid cells--how did we miss them?

Authors:  Jennifer A Walker; Jillian L Barlow; Andrew N J McKenzie
Journal:  Nat Rev Immunol       Date:  2013-01-07       Impact factor: 53.106

Review 6.  Location and cellular stages of natural killer cell development.

Authors:  Jianhua Yu; Aharon G Freud; Michael A Caligiuri
Journal:  Trends Immunol       Date:  2013-09-19       Impact factor: 16.687

7.  Distal-less homeobox transcription factors regulate development and maturation of natural killer cells.

Authors:  John B Sunwoo; Sungjin Kim; Liping Yang; Tina Naik; Darryl A Higuchi; John L Rubenstein; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-29       Impact factor: 11.205

8.  A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells.

Authors:  Aixin Yu; Linjian Zhu; Norman H Altman; Thomas R Malek
Journal:  Immunity       Date:  2009-01-29       Impact factor: 31.745

9.  IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors.

Authors:  Naoko Satoh-Takayama; Sarah Lesjean-Pottier; Paulo Vieira; Shinichiro Sawa; Gerard Eberl; Christian A J Vosshenrich; James P Di Santo
Journal:  J Exp Med       Date:  2010-02-08       Impact factor: 14.307

10.  Dok1 and Dok2 proteins regulate natural killer cell development and function.

Authors:  Javier Celis-Gutierrez; Marilyn Boyron; Thierry Walzer; Pier Paolo Pandolfi; Stipan Jonjić; Daniel Olive; Marc Dalod; Eric Vivier; Jacques A Nunès
Journal:  EMBO J       Date:  2014-06-24       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.